Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    Louisa M. Wootton — scientific profile (based on the 4 listed works)
    The available record shows a focus on HPV-driven cancer biology and oncoprotein/cell-cycle/ubiquitin-regulatory mechanisms, with at least one mechanistic study linking HPV E7 to miRNA repression and proliferation via LASP1.



     Long Explanation


    Author Review: Louisa M. Wootton

    Scope note (skeptical & evidence-limited): Your prompt provides a small set of 4 papers plus OpenAlex-like metadata. I therefore assess scientific content strength strictly from the supplied work list, without extrapolating to the author’s full career.

    Visual: Publication-year span (from supplied works)

    What the supplied works indicate (by mechanism / evidence type)

    1) HPV E7 → miRNA repression → pro-growth signaling axis
    • One supplied primary research article reports that E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    • Scientific strength signal: Mechanism-first framing (viral oncogene → specific regulatory RNA → functional proliferation outcome) is usually a better scaffold for causal inference than purely correlative expression studies—however, causal strength still depends on experimental controls (e.g., rescue experiments, specificity, and model system limitations) that are not provided in your prompt.
    2) Reviews that emphasize multi-pathway HPV carcinogenesis mechanisms
    • A supplied review focuses on mechanisms of human papillomavirus oncoproteins (E6/E7) and how they manipulate multiple cellular pathways leading to cancer-relevant phenotypes.
    • Another supplied review centers on ubiquitin and ubiquitin-like (UBL) proteins in HPV-driven carcinogenesis, linking HPV oncogene action to host protein-regulatory systems such as ubiquitin/proteasome-related regulation.
    3) Cell-cycle/proliferation biomarker orientation (PLK1)
    • A supplied article addresses PLK1 expression and its characteristics and prognostic significance in breast cancer (as framed by the paper title).
    Interpretation caution: Prognostic-expression studies can be vulnerable to confounding (stage, subtype, batch effects, and cohort composition). Without the methods/results details, I can’t assess whether the paper controlled appropriately.

    Visual: How the supplied works connect (themes → evidence types)

    Note: This graph is a conceptual map derived from the supplied paper titles/abstract snippets. It does not encode quantitative effect sizes.

    Evidence-type breakdown (from the provided works)

    Supplied work Year Evidence type (as implied by title label) Primary biological focus
    PLK1 expression & prognosis in breast cancer 2023 Primary research Cell-cycle regulator (PLK1) and clinical relevance
    E7→miR-203 repression→LASP1 proliferation in HPV+ cervical cancer 2024 Primary research Viral oncoprotein control of miRNA regulation and proliferation
    HPV oncoproteins mechanism review 2025 Review Mechanistic synthesis of E6/E7 pathway manipulation
    Ubiquitin/UBL in HPV-driven carcinogenesis review 2025 Review Protein-regulatory systems (ubiquitin/UBL) in carcinogenesis

    Scientific strength & critical blind spots (what we can and can’t conclude)

    Strengths suggested by the supplied record
    • Mechanism continuity across works: The supplied research/review pairings revolve around HPV oncogene-driven regulation and host control systems (miRNA repression; ubiquitin/UBL pathways).
    • Domain relevance: HPV oncogene mechanisms are central to high-risk HPV carcinogenesis discussions, as reflected in the review scope on E6/E7 pathway manipulation.
    Limitations / where uncertainty is high
    • We lack methodological detail: From your prompt alone, I cannot evaluate experimental rigor (e.g., whether the E7/miR-203/LASP1 paper used rescue/epistasis tests, sufficiency/necessity assays, stringency of controls, or relevant model system constraints).
    • Review strength is hard to audit without the full text: Reviews can vary widely in selection criteria, depth, and whether they resolve conflicts; your prompt provides only title/summary-level information.
    • Prognostic biomarker risk: The PLK1 prognostic-signal paper may be vulnerable to cohort/subtype and analysis choices; without methods, it’s not possible to judge causal vs correlational interpretation quality.
    What would most disprove/reshape this assessment?
    • If the mechanistic HPV E7/miR-203/LASP1 study lacks strong specificity tests (e.g., indirect off-target effects, inadequate controls), then “causal axis” confidence should be downgraded.
    • If the reviews are found to omit key contradictory findings or rely on low-quality literature disproportionately, then the “mechanistic synthesis strength” should be reevaluated.


    Feedback:    

    Updated: April 29, 2026

     Hypothesis Graveyard


    That miR-203 repression is the sole driver of LASP1-dependent proliferation (if robust rescue specificity shows other E7-dependent routes dominate, this “single-node” framing weakens).


    That PLK1 expression is a direct mechanistic mediator of prognosis in all breast cancer subtypes (if subtype-stratified analyses show the prognostic signal is mainly correlational, the mediator claim falls).

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending